| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.6M | -86.5% |
| R&D Expense | $224.8M | -17.5% |
| SG&A Expense | $50.9M | -28.9% |
| Operating Income | -$276.0M | +1.6% |
| Interest Expense | $5.3M | +1316.9% |
| Pre-tax Income | -$276.1M | -20.9% |
| Income Tax | $15K | +25.0% |
| Net Income | -$276.1M | -20.9% |
| EPS (Basic) | -$2.61 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $25.8M | -72.2% |
| Short-term Investments | $25.9M | -82.7% |
| Accounts Receivable | $34.1M | -15.2% |
| Inventory | $9.7M | +512.0% |
| Current Assets | $101.9M | -65.5% |
| Total Assets | $165.5M | -56.0% |
| Current Liabilities | $142.2M | +80.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$193.0M | +28.6% |
| Capital Expenditures | $1.2M | -70.8% |
| Investing Cash Flow | $123.9M | -39.0% |
| Financing Cash Flow | $2.0M | -96.2% |
| Free Cash Flow | -$194.2M | +29.3% |
| -16.5% |
| EPS (Diluted) | -$2.61 | -16.5% |
| Total Liabilities |
| $264.7M |
| +6.0% |
| Stockholders' Equity | -$99.2M | -178.4% |